ygrad
hsphharvardedu
establish
mani
peopl
alreadi
infect
urgent
prioriti
control
pandem
patchi
virolog
test
hamper
interpret
confirm
case
count
unknown
rate
asymptomat
mild
infect
make
challeng
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
medrxiv
preprint
third
uncertainti
inher
modelbas
forecast
use
empir
estim
seropreval
regardless
qualiti
test
part
uncertain
relationship
seroposit
immun
clear
evidencebas
guid
aid
design
serolog
studi
critic
polici
maker
public
health
offici
estim
seropreval
forwardlook
model
effort
particularli
serolog
posit
reflect
immun
protect
address
need
develop
framework
use
design
interpret
serolog
studi
applic
start
result
serolog
survey
given
size
age
stratif
framework
incorpor
test
sensit
specif
enabl
estim
popul
seropreval
includ
uncertainti
estim
use
model
diseas
spread
calcul
effect
reproduct
number
r
eff
transmiss
potenti
partial
immun
forecast
diseas
dynam
assess
impact
candid
public
health
clinic
intervent
similarli
start
prespecifi
toler
uncertainti
seropreval
estim
framework
use
defin
sampl
size
need
framework
use
conjunct
model
includ
ode
model
agentbas
simul
network
simul
use
estim
r
eff
simul
transmiss
dynam
velop
evidencebas
public
health
polici
serolog
test
identifi
past
infect
use
estim
cumul
incid
rel
accuraci
robust
variou
sampl
strategi
unclear
use
flexibl
framework
integr
uncertainti
test
characterist
sampl
size
heterogen
seropreval
across
test
subpopul
compar
estim
sampl
scheme
use
framework
make
assumpt
serolog
posit
indic
immun
protect
propag
estim
uncertainti
dynam
model
assess
uncertainti
epidemiolog
paramet
need
evalu
public
health
intervent
examin
rel
accuraci
conveni
sampl
versu
structur
survey
estim
popul
seropreval
found
sampl
scheme
inform
demograph
contact
network
outperform
uniform
sampl
framework
adapt
optim
design
serolog
survey
given
particular
test
characterist
capac
popul
demographi
sampl
strategi
model
approach
tailor
support
decisionmak
around
introduc
remov
intervent
serolog
test
critic
compon
respons
well
futur
epidem
assess
popul
seroposit
measur
preval
individu
infect
past
develop
antibodi
viru
address
gap
knowledg
cumul
diseas
incid
particularli
import
given
inadequ
viral
diagnost
test
incomplet
understand
rate
mild
asymptomat
infect
context
serolog
surveil
potenti
provid
inform
true
number
infect
allow
robust
estim
case
infect
fatal
rate
parameter
epidemiolog
model
evalu
possibl
impact
specif
intervent
thu
guid
public
health
decisionmak
proport
popul
infect
recov
coronaviru
caus
critic
measur
inform
polici
popul
level
includ
social
distanc
intervent
relax
individu
serolog
test
may
allow
lowrisk
individu
return
work
school
colleg
conting
immun
protect
afford
measur
antibodi
respons
popul
level
howev
method
urgent
need
design
interpret
serolog
data
base
test
subpopul
includ
conveni
sampl
like
test
first
reliabl
estim
popul
seropreval
three
sourc
uncertainti
complic
effort
learn
popul
seropreval
subsampl
first
test
may
imperfect
sensit
specif
estim
test
market
april
report
specif
sensit
supplementari
tabl
second
popul
sampl
like
repres
random
sampl
particularli
first
round
test
urgenc
test
use
conveni
sampl
potenti
limit
serolog
test
capac
test
sensitivityspecif
sampl
bia
true
seropreval
influenc
accuraci
robust
estim
integr
uncertainti
aris
test
sensit
specif
produc
bayesian
posterior
distribut
seropreval
accommod
uncertainti
associ
finit
sampl
size
fig
green
annot
denot
posterior
probabl
true
popul
serolog
equal
given
test
outcom
data
x
test
sensit
specif
characterist
pr
x
sampl
size
outcom
includ
x
test
sensit
specif
includ
calcul
posterior
distribut
appropri
handl
uncertainti
see
method
illustr
use
calcul
practic
first
simul
serolog
data
popul
seropreval
rate
rang
use
report
sensit
specif
test
approv
sale
eu
supplementari
tabl
number
sampl
rang
next
construct
bayesian
posterior
estim
seropreval
see
method
find
seropreval
lower
around
sampl
necessari
estim
seropreval
within
two
percentag
point
fig
test
characterist
requir
around
test
sensit
specif
supplementari
fig
test
sensit
specif
supplementari
fig
achiev
uncertainti
level
rel
minimum
around
test
theoret
test
perfect
sensit
specif
supplementari
fig
sampl
framework
seroposit
estim
like
nonrandom
constrain
subpopul
therefor
although
gener
estim
uncertain
true
seroposit
near
number
sampl
low
andor
test
sensitivityspecif
low
fig
supplementari
fig
anoth
sourc
statist
uncertainti
come
potenti
uneven
distribut
sampl
across
popul
variat
true
posit
extrapol
seroposit
sampl
particular
subpopul
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
fie
bayesian
hierarch
model
introduc
common
prior
distribut
subpopulationspecif
seroposit
see
method
effect
allow
seroposit
estim
individu
subpopul
inform
still
take
account
subpopulationspecif
test
outcom
conveni
sampl
test
blood
sampl
obtain
anoth
purpos
readili
avail
often
easiest
quickest
data
collect
method
two
exampl
conveni
sampl
newborn
heel
stick
dri
blood
spot
contain
matern
antibodi
thu
reflect
matern
exposur
serum
blood
donor
sampl
may
also
design
repres
broader
rang
popul
random
uniform
sampl
across
age
group
sampl
inform
popul
demograph
sampl
relat
expect
contribut
transmiss
exampl
base
agestructur
contact
matrix
term
latter
sampl
scheme
model
demograph
inform
sampl
test
abil
bayesian
hierarch
model
describ
infer
popul
subpopul
seropreval
even
conveni
sampl
avail
credibl
interv
result
overal
seropreval
estim
influenc
age
demograph
sampl
uncertainti
newborn
dri
blood
spot
sampl
set
due
narrow
age
rang
mother
fig
sampl
strategi
draw
subset
popul
mathemat
approach
assum
seropreval
subpopul
dramat
vari
thu
infer
seropreval
unsampl
bin
similar
sampl
bin
increas
uncertainti
method
supplementari
text
uncertainti
also
influenc
overal
seropreval
width
credibl
interv
increas
higher
seropreval
given
sampl
size
test
sensit
specif
also
impact
uncertainti
central
estim
overal
seroposit
robust
sampl
strategi
span
entir
popul
seropreval
estim
inform
uncertainti
epidem
peak
time
natur
extens
use
serolog
data
estim
core
epidemiolog
quantiti
map
pattern
outbreak
risk
posterior
distribut
seropreval
use
input
epidemiolog
model
includ
typic
seir
model
proport
seroposit
may
correspond
recoveredimmun
compart
complex
framework
agestructur
seir
model
incorpor
intervent
like
close
school
social
distanc
fig
blue
annot
integr
uncertainti
posterior
estim
seropreval
uncertainti
model
dynam
paramet
use
mont
carlo
sampl
produc
posterior
distribut
trajectori
key
epidemiolog
paramet
estim
fig
black
annot
figur
illustr
estim
height
time
peak
infect
vari
two
serolog
sampl
scenario
two
hypothet
social
distanc
polici
basic
seir
framework
parameter
use
seropreval
data
uncertainti
seropreval
estim
propag
seir
model
output
stage
larger
sampl
size
given
seropreval
result
smaller
credibl
interv
seropreval
estim
improv
precis
estim
height
time
epidem
peak
case
assum
serolog
test
sensit
specif
respect
test
characterist
also
impact
model
estim
specif
sensit
test
lead
precis
estim
supplementari
fig
even
estim
perfect
test
carri
uncertainti
correspond
size
sampl
set
supplementari
fig
conveni
sampl
particular
age
group
agestratifi
serolog
survey
bayesian
hierarch
model
extrapol
seropreval
sampl
subpopul
overal
popul
uncertainti
propag
estim
modelinf
epidemiolog
paramet
interest
r
eff
estim
neonat
heel
stick
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
blood
donat
achiev
uncertain
still
reason
estim
overal
seropreval
r
eff
compar
uniform
demograph
inform
sampl
set
fig
conveni
sampl
produc
higher
confid
estim
test
subpopul
high
uncertainti
estim
unsampl
popul
bayesian
model
framework
scenario
framework
propag
uncertainti
appropri
serolog
input
estim
overal
seropreval
r
eff
improv
test
sensit
specif
correspondingli
improv
estim
reduc
number
sampl
would
requir
achiev
credibl
interv
given
seropreval
would
similarli
reduc
sampl
need
equival
estim
r
eff
supplementari
fig
subpopul
conveni
sampl
systemat
differ
seropreval
gener
popul
increas
sampl
size
may
bia
estim
supplementari
fig
avoid
use
data
sourc
updat
bayesian
prior
distribut
known
hypothes
relationship
seropreval
sampl
unsampl
popul
strateg
sampl
alloc
improv
estim
flexibl
framework
describ
fig
enabl
calcul
sampl
size
differ
serolog
survey
design
calcul
number
test
requir
achiev
seropreval
estim
specifi
toler
uncertainti
alloc
test
accord
specif
subpopul
context
particular
intervent
treat
eventu
estim
uncertainti
framework
output
sought
minim
improv
alloc
sampl
fig
dash
arrow
uniform
alloc
sampl
across
subpopul
alway
optim
improv
upon
increas
sampl
subpopul
higher
seropreval
ii
increas
sampl
subpopul
higher
rel
influenc
quantiti
estim
approach
term
model
demograph
inform
mdi
alloc
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
sampl
subpopul
proport
much
sampl
would
decreas
po
probabl
posit
test
subpopul
given
test
sensit
se
test
specif
sp
subpopul
seropreval
x
rel
import
subpopul
quantiti
estim
quantiti
overal
seropreval
x
fraction
popul
subpopul
quantiti
total
infect
r
eff
x
deriv
structur
model
see
method
subpopul
preval
estim
unknown
sampl
alloc
base
sole
x
recommend
demonstr
effect
mdi
sampl
alloc
use
design
strategi
optim
estim
r
eff
test
perform
sampl
alloc
blood
donat
neonat
heel
stick
uniform
sampl
mdi
produc
higher
confid
posterior
estim
fig
supplementari
fig
importantli
rel
import
subpopul
model
may
vari
base
hypothet
intervent
model
eg
reopen
workplac
would
place
higher
import
serolog
statu
workingag
adult
mdi
sampl
alloc
recommend
may
deriv
multipl
hypothet
intervent
averag
design
studi
largest
varieti
highconfid
result
deriv
see
recommend
would
work
practic
comput
mdi
recommend
optim
three
scenario
contact
pattern
demographi
us
india
deriv
balanc
sampl
recommend
fig
critic
need
serolog
surveil
estim
cumul
incid
present
formal
framework
aid
design
interpret
serolog
studi
consid
sampl
may
done
vari
way
includ
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
broad
initi
effort
approxim
seropreval
use
conveni
sampl
well
complex
resourceintens
structur
sampl
scheme
effort
may
use
one
number
serolog
test
distinct
test
characterist
incorpor
framework
approach
propag
estim
associ
uncertainti
mathemat
model
diseas
transmiss
focus
scenario
seropreval
map
immun
provid
decisionmak
tool
evalu
potenti
impact
intervent
thu
guid
polici
develop
implement
result
suggest
approach
serolog
surveil
adapt
need
base
preexist
knowledg
diseas
preval
trajectori
avail
conveni
sampl
extent
resourc
put
toward
structur
survey
design
implement
absenc
baselin
estim
seropreval
initi
survey
provid
preliminari
estim
popul
preval
fig
framework
updat
rule
approach
incorpor
uncertainti
test
characterist
address
uncertainti
bias
sampl
scheme
see
supplementari
text
result
conveni
sampl
newborn
heel
stick
dri
blood
spot
sampl
blood
donor
use
estim
popul
seropreval
howev
import
note
absenc
reliabl
assess
correl
seropreval
across
age
group
extrapol
conveni
sampl
may
mislead
sampl
size
increas
supplementari
fig
uniform
model
demograph
inform
sampl
challeng
logist
implement
give
reliabl
estim
result
onetim
studi
could
use
updat
prior
bayesian
hierarch
model
improv
infer
conveni
sampl
context
note
mathemat
framework
natur
allow
integr
sampl
multipl
test
kit
protocol
provid
sensit
specif
estim
becom
use
serolog
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
assay
improv
specif
result
serolog
survey
invalu
project
epidem
trajectori
understand
impact
introduc
stop
intervent
shown
estim
serolog
survey
propag
transmiss
model
incorpor
model
uncertainti
well
convers
aid
rigor
assess
particular
intervent
meet
accuraci
precis
specif
framework
use
determin
need
number
distribut
popul
sampl
via
model
demograph
inform
sampl
number
limit
approach
reflect
uncertainti
underli
assumpt
serolog
respons
chang
mobil
interact
arisen
respons
public
health
mitig
effort
social
distanc
serolog
reflect
past
infect
delay
infect
detect
immun
respons
mean
serolog
test
reflect
histor
cumul
incid
date
sampl
minu
delay
infect
detect
respons
possibl
heterogen
immun
respons
infect
unknown
dynam
durat
immun
respons
mean
interpret
serolog
survey
result
may
accur
captur
cumul
incid
yet
understand
serolog
correl
protect
infect
project
seropreval
model
assum
seroposit
indic
immun
reinfect
may
overestim
model
would
need
updat
includ
partial
protect
return
suscept
use
model
demographicinform
sampl
scheme
valuabl
project
evalu
intervent
depend
accur
parameter
exampl
use
polymod
contact
matric
repres
statu
quo
ant
updat
extent
possibl
use
data
obtain
survey
mobil
data
onlin
platform
mobil
phone
moreov
framework
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
could
extend
geograph
heterogen
well
longitudin
sampl
exampl
one
want
compar
whether
estim
quantiti
interest
eg
seropreval
r
eff
differ
across
locat
time
overal
framework
adapt
commun
vari
size
resourc
seek
monitor
respond
pandem
analys
discuss
focus
address
urgent
need
generaliz
framework
appropri
modif
applic
infecti
diseas
epidem
ulat
iset
equal
zero
unsampl
subpopulationsth
posterior
distribut
vector
subpopul
seroposit
given
includ
hierarchi
prior
specif
prior
subpopul
singlepopul
simul
infer
simul
sampl
infer
fig
n
serolog
sampl
drawn
popul
seropreval
includ
fals
posit
neg
result
dictat
test
model
see
supplementari
tabl
given
test
outcom
posterior
distribut
infer
use
sampl
posterior
distribut
eq
use
acceptreject
algorithm
equaltail
credibl
interv
record
averag
posterior
ci
width
calcul
use
technic
replic
per
pixelpoint
fig
tabl
posterior
distribut
eq
sampl
time
use
acceptreject
algorithm
sampl
use
initi
condit
seir
simul
describ
isol
effect
sampl
size
alon
outcom
n
test
scale
tenfold
total
n
test
procedur
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
repeat
compar
differ
test
kit
sampl
gener
kit
produc
expect
number
truefals
positiveneg
outcom
supplementari
tabl
fig
supplementari
fig
agestructur
simul
infer
simul
sampl
infer
fig
n
n
serolog
sampl
alloc
subpopul
heterogen
seropreval
valu
supplementari
tabl
shift
upward
downward
achiev
target
overal
seropreval
simul
test
outcom
includ
fals
posit
neg
result
dictat
test
model
see
supplementari
tabl
test
alloc
n
done
proport
age
demograph
blood
donat
deliv
mother
uniformli
across
subpopul
accord
varianc
reduct
strategi
mdi
see
given
persubpopul
test
outcom
sampl
drawn
posterior
distribut
eq
use
mcmc
supplementari
materi
posterior
distribut
overal
seropreval
produc
demograph
weight
averag
agespecif
seropreval
sampl
posterior
distribut
r
eff
produc
use
sampl
agespecif
seropreval
agestructur
model
describ
overal
seropreval
r
eff
equaltail
credibl
interv
record
averag
posterior
ci
width
calcul
use
technic
replic
per
pixelpoint
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
n
simul
fraction
recov
individu
assum
immun
sampl
valu
peak
infect
height
time
extract
forwardintegr
timeseri
model
describ
fulli
supplementari
materi
agestructur
model
model
parameter
use
countryspecif
agecontact
pattern
paramet
estim
model
due
includ
agespecif
clinic
fraction
vari
durat
preclin
clinic
subclin
infecti
well
decreas
infecti
subclin
case
r
eff
agespecif
seroposit
estim
calcul
princip
eigenvalu
serologyadjust
nextgenerationmatrix
fraction
total
popul
subpopul
n
absenc
prior
inform
alloc
sampl
minim
posterior
uncertainti
associ
compartment
model
subpopul
inclus
model
intervent
mdi
rec
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
demograph
contact
data
demograph
data
us
india
download
unit
nation
world
popul
prospect
report
age
distribut
us
blood
donor
drawn
studi
atlanta
donor
age
distribut
us
mother
drawn
cdc
vital
statist
report
use
massachusett
refer
state
daili
agestructur
contact
data
drawn
prem
et
al
data
repres
use
age
bin
ie
dataset
bin
wider
year
count
distribut
evenli
fiveyear
bin
serolog
test
sensit
specif
valu
serolog
test
characterist
collect
websit
manufactur
summar
supplementari
tabl
attempt
made
test
valid
manufactur
claim
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
figur
uncertainti
overal
seropreval
estim
conveni
formal
sampl
strategi
uncertainti
repres
width
credibl
interv
present
seropreval
percentag
point
base
serolog
test
sensit
specif
supplementari
fig
depict
result
sensit
specif
valu
curv
show
decreas
averag
ci
width
seropreval
illustr
advantag
use
uniform
mdi
sampl
conveni
sampl
b
heatmap
show
averag
ci
width
variou
total
sampl
count
overal
seropreval
conveni
sampl
deriv
newborn
blood
spot
us
blood
donor
improv
addit
sampl
retain
baselin
uncertainti
due
demograph
cover
conveni
sampl
estim
overal
seropreval
uniform
sampl
margin
superior
exampl
model
demograph
inform
mdi
sampl
strategi
design
optim
estim
r
eff
point
pixel
averag
stochast
draw
specifi
seropreval
indic
sensit
specif
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
four
sampl
strategi
n
test
alloc
age
group
neg
test
grey
posit
test
color
shown
test
sensit
specif
mdi
strategi
shown
design
optim
estim
r
eff
eh
agegroup
seropreval
estim
shown
boxplot
box
ci
whisker
ci
dot
indic
true
valu
data
sampl
note
decreas
uncertainti
box
higher
sampl
rate
agegroup
seropreval
weight
popul
demograph
produc
overal
seropreval
estim
shown
probabl
densiti
credibl
interv
shade
highlight
dash
line
j
agegroup
seropreval
use
estim
r
eff
statu
quo
ant
contact
pattern
shown
probabl
densiti
credibl
interv
shade
highlight
dash
line
dash
line
indic
true
valu
data
sampl
distribut
depict
infer
outcom
singl
sent
stochast
sampl
data
averag
done
note
although
uniform
sampl
alloc
produc
confid
estim
overal
seropreval
mdi
produc
confid
estim
r
eff
sinc
alloc
sampl
age
group
relev
model
dynam
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
bayesian
infer
method
infer
seropreval
sampl
use
imperfect
test
serolog
test
perfect
sensit
specif
probabl
observ
n
seroposit
n
seroneg
result
n
test
given
true
popul
seropreval
given
binomi
distribut
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
howev
imperfect
specif
sensit
requir
modifi
formula
conveni
remaind
supplement
text
use
u
pr
test
posit
seroneg
specif
v
pr
test
neg
seroposit
sensit
use
notat
probabl
singl
test
return
posit
result
given
u
v
true
seropreval
substitut
persampl
probabl
eq
yield
final
use
bay
rule
write
posterior
distribut
seroposit
given
data
test
paramet
uninform
uniform
prior
yield
b
incomplet
beta
function
without
normal
practic
sampl
distribut
one
use
acceptreject
algorithm
consid
numer
eq
sampl
joint
posterior
distribut
insid
integr
eq
use
markov
chain
mont
carlo
mcmc
algorithm
univari
metropolishast
updat
initi
agespecif
seroprevel
paramet
n
n
equal
sampl
mean
set
simul
mcmc
algorithm
run
total
iter
first
iter
discard
everi
sampl
save
obtain
sampl
joint
posterior
distribut
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
calcul
follow
reli
fact
optim
theori
briefli
review
appli
result
follow
let
n
n
n
k
suppos
want
minim
function
form
subject
constraint
n
n
use
method
lagrang
multipli
shown
f
n
minim
n
c
appli
result
variou
express
c
determin
optim
alloc
n
test
across
subpopul
order
minim
uncertainti
quantiti
interest
given
agespecif
seropreval
estim
estim
overal
seropreval
de
maximum
likelihood
estim
given
n
posit
test
n
test
administ
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
valid
numer
denomin
posit
correspond
valu
interv
estim
comput
found
neg
happen
fraction
test
posit
fals
posit
rate
maximum
likelihood
lie
endpoint
similarli
estim
found
greater
one
estim
undefin
test
alloc
group
ie
n
use
maximum
likelihood
estim
proxi
subpopul
posterior
distribut
approxim
posterior
varianc
pop
true
seropreval
group
varianc
equat
form
eq
thu
optim
alloc
sampl
given
absenc
knowledg
true
subpopul
seropreval
recommend
simpli
alloc
sampl
respect
demograph
inform
n
primari
quantiti
interest
output
model
improv
test
alloc
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
defin
eq
modif
eq
next
gener
matrix
updat
vector
infect
individu
per
subpopul
x
repres
eigenvector
n
correspond
largest
eigenvalu
k
preliminari
calcul
mind
turn
estim
h
h
h
valu
h
function
random
variabl
h
also
random
variabl
goal
minim
varianc
strateg
alloc
finit
sampl
order
minim
import
posterior
varianc
among
element
plain
languag
subpopul
import
shape
futur
diseas
dynam
other
mdi
preferenti
alloc
sampl
subpopul
principl
manner
next
gener
matrix
n
nonneg
satisfi
condit
perronfrobeniu
theorem
mean
largest
eigenvalu
next
gener
matrix
r
greater
equal
eigenvalu
correspond
eigenvector
x
nonneg
compon
mean
repeat
applic
n
initi
vector
orthogon
x
becom
increasingli
parallel
x
rate
per
iter
second
largest
eigenvalu
n
basi
socal
power
method
repeatedli
appli
matrix
find
largest
eigenvalu
correspond
eigenvector
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
deriv
eq
approxim
posterior
varianc
posterior
varianc
correspond
maximum
likelihood
result
follow
approxim
varianc
total
number
infect
x
ith
element
princip
eigenvector
x
first
express
obtain
use
approxim
eq
result
varianc
express
form
eq
thu
ignor
constant
optim
alloc
sampl
given
absenc
knowledg
true
subpopul
seropreval
recommend
simpli
alloc
sampl
respect
entri
princip
eigenvector
n
x
let
e
r
number
suscept
expos
infect
recov
peopl
popul
size
n
e
r
n
model
dynam
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
parameter
model
use
seropreval
made
model
assumpt
seroposit
individu
immun
note
assumpt
present
requir
indepth
research
therefor
place
seroposit
individu
recov
group
word
seroposit
fraction
individu
e
compart
initi
condit
would
paramet
valu
use
studi
found
supplementari
tabl
model
introduc
estim
davi
et
al
consid
seir
model
sixteen
age
group
age
contact
parameter
polymodtyp
estim
dynam
includ
clinic
subclin
infect
correspond
preclin
clinic
subclin
infecti
paramet
durat
lower
infecti
among
subclin
infect
comput
r
davi
et
al
defin
next
gener
matrix
n
entri
u
suscept
age
group
c
ij
number
agej
individu
contact
agei
individu
per
day
probabl
infect
clinic
agei
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
individu
p
c
mean
durat
preclin
clinic
subclin
infecti
respect
f
rel
infecti
subclin
case
valu
paramet
report
supplementari
tabl
protect
seroposit
includ
model
multipli
n
ij
defin
seroposit
rate
agegroup
includ
term
modifi
eq
x
repres
diagon
matrix
entri
ii
x
constant
defin
p
c
f
b
effect
reproduct
number
spectral
radiu
ie
largest
eigenvalu
next
gener
matrix
written
eq
repres
model
compon
shown
fig
blue
annot
map
paramet
point
estim
r
eff
canon
seir
model
uncertainti
model
paramet
also
incorpor
overal
uncertainti
r
eff
via
mont
carlo
impact
sensit
specif
rule
suppos
perfect
test
u
v
perform
n
test
zero
posit
maximum
likelihood
estim
seropreval
would
propos
simpl
upper
confid
bound
true
seropreval
equal
deriv
rule
motiv
follow
question
maximum
seropreval
probabl
observ
zero
posit
n
test
less
equal
briefli
probabl
neg
test
thu
probabl
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
observ
n
neg
test
n
set
equal
solv
find
approxim
base
power
seri
represent
exponenti
function
let
consid
happen
sensit
specif
equal
one
zero
posit
test
observ
probabl
neg
test
upper
confid
bound
true
seropreval
approxim
deriv
similar
manner
notic
u
upper
bound
less
zero
occur
inconsist
specifi
fals
posit
rate
u
observ
data
name
occur
n
larg
enough
would
expect
least
one
fals
posit
even
seropreval
zero
expect
observ
number
posit
test
simpli
due
imperfect
test
specif
suppos
observ
n
posit
test
sampl
n
approxim
upper
confid
bound
true
seropreval
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
figur
uncertainti
popul
seropreval
estim
function
number
sampl
true
popul
rate
uncertainti
repres
width
credibl
interv
present
seropreval
percentag
point
heatmap
select
seropreval
valu
base
serolog
test
sensit
specif
match
claim
cellex
test
b
e
sensit
specif
match
claim
aytu
igg
test
c
f
sensit
specif
repres
ideal
test
complement
result
test
sensit
specif
shown
main
text
fig
see
supplementari
tabl
detail
serolog
test
kit
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
figur
uncertainti
overal
seropreval
estim
conveni
formal
sampl
strategi
uncertainti
repres
width
credibl
interv
present
seropreval
percentag
point
base
serolog
test
b
sensit
specif
match
claim
cellex
test
c
sensit
specif
match
claim
aytu
igg
test
e
f
sensit
specif
repres
ideal
test
complement
result
test
sensit
specif
shown
main
text
fig
c
e
curv
show
decreas
averag
ci
width
seropreval
illustr
advantag
use
uniform
mdi
sampl
conveni
sampl
b
f
heatmap
show
averag
ci
width
variou
total
sampl
count
overal
seropreval
conveni
sampl
deriv
newborn
blood
spot
us
blood
donor
improv
addit
sampl
retain
baselin
uncertainti
due
demograph
cover
conveni
sampl
estim
overal
seropreval
uniform
sampl
margin
superior
exampl
model
demograph
inform
mdi
sampl
strategi
design
optim
estim
r
eff
point
pixel
averag
stochast
draw
specifi
seropreval
indic
sensit
specif
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
figur
uncertainti
serolog
data
produc
uncertainti
estim
epidem
peak
height
time
even
test
perfect
sensit
specif
serolog
test
outcom
n
test
b
n
test
produc
shown
bar
graph
four
test
sensit
specif
valu
indic
serolog
test
sampl
gener
stochast
instead
accord
expect
highlight
sensit
specif
affect
infer
posterior
seropreval
estim
c
n
n
scenario
reveal
bayesian
estim
place
posterior
correct
valu
uncertainti
depend
n
compar
c
test
characterist
compar
peak
height
yellow
purpl
blue
orang
sampl
seropreval
posterior
produc
distribut
epidem
curv
scenario
social
distanc
see
method
lead
uncertainti
e
height
epidem
peak
f
time
epidem
peak
uncertainti
mitig
elimin
n
scenario
uncertainti
mitig
elimin
use
perfect
serolog
test
boxplot
reflect
sampl
seir
dynamimc
whisker
span
box
span
central
quartil
line
indic
median
outlier
shown
see
method
seir
simul
detail
paramet
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
figur
credibl
interv
coverag
overal
seropreval
estim
use
four
sampl
strategi
four
serolog
test
kit
credibl
interv
coverag
defin
fraction
posterior
credibl
interv
cover
true
paramet
use
gener
data
shown
four
sampl
strategi
column
color
four
test
kit
row
sensit
specif
valu
indic
see
legend
point
repres
fraction
credibl
interv
cover
plant
valu
indic
overal
seropreval
valu
see
annot
plot
specifi
number
serolog
sampl
n
total
independ
trial
estim
coverag
perfectli
calibr
posterior
coverag
fraction
within
grey
band
time
seropreval
valu
plot
black
simpli
guid
eye
mdi
strategi
shown
design
optim
estim
r
eff
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
figur
averag
credibl
interv
width
overal
seropreval
estim
use
four
sampl
strategi
four
serolog
test
kit
credibl
interv
calcul
data
gener
accord
four
sampl
strategi
column
color
four
test
kit
row
sensit
specif
valu
indic
see
legend
point
repres
averag
width
interv
indic
overal
seropreval
valu
see
annot
plot
specifi
number
serolog
sampl
n
total
independ
trial
seropreval
valu
plot
black
simpli
guid
eye
mdi
strategi
shown
design
optim
estim
r
eff
sampl
strategi
result
posterior
credibl
interv
inaccur
coverag
see
supplementari
fig
cross
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
figur
credibl
interv
coverag
r
eff
estim
use
four
sampl
strategi
four
serolog
test
kit
credibl
interv
coverag
defin
fraction
posterior
credibl
interv
cover
true
paramet
use
gener
data
shown
four
sampl
strategi
column
color
four
test
kit
row
sensit
specif
valu
indic
see
legend
point
repres
fraction
credibl
interv
cover
plant
valu
indic
overal
seropreval
valu
see
annot
plot
specifi
number
serolog
sampl
n
total
independ
trial
estim
coverag
perfectli
calibr
posterior
coverag
fraction
within
grey
band
time
seropreval
valu
plot
black
simpli
guid
eye
mdi
strategi
shown
design
optim
estim
r
eff
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
figur
averag
credibl
interv
width
r
eff
estim
use
four
sampl
strategi
four
serolog
test
kit
credibl
interv
calcul
data
gener
accord
four
sampl
strategi
column
color
four
test
kit
row
sensit
specif
valu
indic
see
legend
point
repres
averag
width
interv
indic
overal
seropreval
valu
see
annot
plot
specifi
number
serolog
sampl
n
total
independ
trial
seropreval
valu
plot
black
simpli
guid
eye
mdi
strategi
shown
design
optim
estim
r
eff
sampl
strategi
result
posterior
credibl
interv
inaccur
coverag
see
supplementari
fig
cross
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
tabl
serolog
test
use
studi
sensit
specif
valu
taken
manufactur
claim
april
compil
john
hopkin
center
health
secur
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
tabl
paramet
valu
use
model
tabl
divid
two
section
top
section
correspond
paramet
singlepopul
seir
model
bottom
section
correspond
paramet
use
agestructur
seir
model
contact
matric
c
ij
use
manuscript
particular
correspond
unit
state
america
india
valu
probabl
infect
clinic
agei
individu
gener
use
three
control
point
young
middl
old
age
interpol
cosinesmooth
function
describ
equat
model
found
supplementari
text
test
kit
sensit
specif
valu
provid
supplementari
tabl
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
